1. Home
  2. KNRX vs CRVO Comparison

KNRX vs CRVO Comparison

Compare KNRX & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KNRX

KNOREX LTD. Class A Ordinary Shares

N/A

Current Price

$1.00

Market Cap

30.3M

Sector

Technology

ML Signal

N/A

Logo CervoMed Inc.

CRVO

CervoMed Inc.

HOLD

Current Price

$3.76

Market Cap

35.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KNRX
CRVO
Founded
2009
2001
Country
Singapore
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.3M
35.9M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
KNRX
CRVO
Price
$1.00
$3.76
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$23.00
AVG Volume (30 Days)
284.6K
35.2K
Earning Date
06-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,006,510.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.76
$3.51
52 Week High
$3.45
$13.13

Technical Indicators

Market Signals
Indicator
KNRX
CRVO
Relative Strength Index (RSI) 37.97 46.95
Support Level $0.97 $3.57
Resistance Level $1.46 $4.33
Average True Range (ATR) 0.15 0.23
MACD -0.03 0.03
Stochastic Oscillator 15.85 40.52

Price Performance

Historical Comparison
KNRX
CRVO

About KNRX KNOREX LTD. Class A Ordinary Shares

Knorex Ltd is a B2B technology company providing programmatic advertising products and solutions to marketers to streamline and automate their advertising and marketing workflows. Its software offers marketers cost-effective solutions and productivity-enhancing capabilities to target audience across various advertising channels and devices through automated processes and algorithms, which is known as programmatic advertising. Its product, Knorex XPOSM, is a self-service enterprise-grade cloud platform with a suite of advertising management and execution (AMX) applications. The Company operates in one operating segment, which focuses on platform subscription fee, platform services, managed activations, and professional services.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: